Clinical evaluation of enhanced nonablative skin rejuvenation using a combination of a 532 and a 1,064 nm laser

Lasers in Surgery and Medicine
M TanBrigitte Stewart

Abstract

Improvements in the physical signs of photoaging can be achieved by non-invasive laser resurfacing procedures. To evaluate the effectiveness and safety of the Nd:YAG 1,064 nm and KTP 532 nm lasers for non-invasive skin rejuvenation. Subjects requesting non-invasive skin rejuvenation underwent two treatments with the 532 nm laser to one side of the face and with both lasers to the other side, followed by three treatments with the 1,064 nm laser to both sides. Skin characteristics were evaluated before, during, and up to 4 months after treatment. A >25% improvement in overall skin condition was observed for >30% of subjects at the 1 month follow-up and >40% of subjects at the 4 month follow-up. The greatest improvements were observed for visual dryness, roughness, and uneven pigmentation. No adverse events were reported. There was a trend for greater improvement in patients who received more 1,064 nm treatments but this was not statistically significant. The 532 nm KTP and 1,064 nm Nd: YAG lasers can be effectively and safely used for non-invasive skin rejuvenation.

References

Jul 1, 1981·The Journal of Investigative Dermatology·R R Anderson, J A Parrish
Feb 26, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·M P GoldmanR E Fitzpatrick
Dec 29, 2000·Lasers in Surgery and Medicine·R E FitzpatrickN Marchell
May 22, 2001·Journal of Cutaneous Laser Therapy·D J Goldberg
Jul 12, 2001·Journal of Cutaneous Laser Therapy·P BjerringM Kiernan
Oct 22, 2003·Archives of Dermatology·Min-Wei Christine Lee
Nov 19, 2003·Archives of Facial Plastic Surgery·Paul J CarniolAdam Friedman

❮ Previous
Next ❯

Citations

Jul 14, 2010·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Emily P Tierney, C William Hanke
Sep 24, 2005·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Girish S MunavalliRebat M Halder
May 5, 2007·Journal of Biomedical Optics·Gentiana I WenzelJohn S Oghalai
Jul 1, 2010·Journal of Pharmaceutical Sciences·Clara GómezM Dolores Blanco
Apr 28, 2012·Facial Plastic Surgery Clinics of North America·Elizabeth F Rostan
Oct 10, 2015·Journal of Biophotonics·Hazel Garvie-CookSergey N Gordeev
Jun 17, 2008·Dermatologic Clinics·Amy F Taub
Sep 18, 2007·Clinics in Dermatology·Danielle M DeHoratius, Jeffrey S Dover
Aug 16, 2006·Facial Plastic Surgery Clinics of North America·Paul J Carniol, Sterling Baker
Oct 19, 2005·Dermatologic Therapy·Christine C Dierickx, R Rox Anderson
Jun 18, 2009·Lasers in Surgery and Medicine·Peter BjerringJaap de Leeuw
Jan 26, 2007·Lasers in Surgery and Medicine·Hans LaubachDieter Manstein
Dec 16, 2006·Journal of Cosmetic Dermatology·Vasiliki A NikolaouJeffrey S Dover
Feb 20, 2009·Lasers in Surgery and Medicine·Dieter MansteinHenry H Chan
Oct 5, 2010·Lasers in Surgery and Medicine·Dina YaghmaiMary C Massa
Jan 16, 2010·Lasers in Surgery and Medicine·Siremon ThongsimaDieter Manstein
Apr 18, 2016·Journal of the American Academy of Dermatology·Molly WannerR Rox Anderson
Nov 20, 2008·Archives of Facial Plastic Surgery·Edward C Wu, Brian J F Wong
Jul 16, 2005·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Marco Dal Canton, Eliana Modolo
Oct 8, 2009·American Journal of Rhinology & Allergy·Eitan YanivBen Nageris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.